Memorias do Instituto Oswaldo Cruz

Papers
(The TQCC of Memorias do Instituto Oswaldo Cruz is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress55
Sublingual microcirculatory alterations in Chagas disease: an observational study in an endemic rural population37
Insecticide resistance levels and associated mechanisms in three Aedes aegypti populations from Venezuela32
First concrete documentation for presence of Aedes (Stegomyia) albopictus in Bolivia: dispelling previous anecdotes30
PPE59 antibodies in tuberculous patients and potential use for diagnosis when assayed with other rapid biomarkers29
Impact of dengue virus infection on the cytoadherence of Plasmodium vivax-infected erythrocytes22
Genome characterisation of the first isolate of human enterovirus c99 from an acute flaccid paralysis case in Brazil22
A multicentre comparative study of serological methods for diagnosing Chagas disease in Brazil17
Genomic surveillance: a potential shortcut for effective Chagas disease management17
Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population16
Memórias do Instituto Oswaldo Cruz celebrates 115 years of scientific publishing: what it needs to keep moving on…16
Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection16
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress16
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day15
Why do we still have not a vaccine against Chagas disease?15
Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites12
Plants of the family Lamiaceae as a source of therapeutic agents against Acanthamoeba infections12
Challenges in developing new tuberculosis vaccines11
Characterisation of Neisseria meningitidis cc11/ET-15 variant by whole genome sequencing11
Intravenous whole blood transfusion results in faster recovery of vascular integrity and increased survival in experimental cerebral malaria10
Trypanosoma cruzi and Chagas disease: diversity, progress and challenges10
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease10
Surveillance of land molluscs infected by Angiostrongylus cantonensis (Nematoda) reveals risk areas for zoonotic eosinophilic meningitis in the State of Rio de Janeiro, Brazil9
In vitro activity of Schinus terebinthifolius extract and fractions against Sporothrix brasiliensis9
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field9
Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’8
Cross-sectional entomological monitoring combined with professional qualifications in transition areas for yellow fever and autochthonous malaria in the Atlantic Forest in Rio de Janeiro, Brazil8
Heterochromatin protein 1 (HP1) of Schistosoma mansoni: non-canonical chromatin landscape and oviposition effects8
Perillyl alcohol modulates activation, permeability and integrity of human brain endothelial cells induced by Plasmodium falciparum7
Iron and vitamin D intake on a diet are able to modify the in vitro immune response to Mycobacterium leprae7
A review of serological tests available in Brazil for intestinal schistosomiasis diagnosis7
Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy7
Polyunsaturated fatty acids alter the formation of lipid droplets and eicosanoid production in Leishmania promastigotes7
Diphtheria antitoxin treatment: from pioneer to neglected6
Leishmania (Leishmania) infantum DNA detection in Nyssomyia neivai in Vale do Ribeira, Paraná, Brazil6
Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis6
Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide6
Congenital Zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface6
Chagas disease in the context of the 2030 agenda: global warming and vectors6
First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil6
125 years of the plague in Brazil: lessons learnt, historical insights and contemporary challenges6
Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target6
Heavy metal resistance in the Yanomami and Tunapuco microbiome6
Concomitant occurrence of chronic Schistosoma mansoni infection and chronic colitis restore immune imbalance and dysbiosis leading to protection against intestinal colitis and schistosome egg-induced 5
Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease5
Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes5
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment5
Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains5
Reflections on Chagas disease in the Amazon4
Chikungunya virus infection in the southernmost state of Brazil was characterised by self-limited transmission (2017-2019) and a larger 2021 outbreak4
Exploring BCG to deliver avidin fusion antigens from Schistosoma mansoni4
Challenges and perspectives in research and teaching of host pathogen interaction topics: new post-pandemic times to Brazil and other South American countries4
Pathophysiology and new targets for therapeutic options in Chagas heart disease4
Increased angiogenesis parallels cardiac tissue remodelling in experimental acute Trypanosoma cruzi infection4
Investigating the distribution of a rare Colombo-Venezuelan kissing bug, Rhodnius neivai, Lent, 1953, using geographical information system-based analyses4
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole4
The risk of vector transmission of Trypanosoma cruzi remains high in the State of Paraná4
Aedes aegypti reproductive aspects: constant light significantly affects the embryonic development4
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon3
A newly bat-borne hantavirus detected in Seba’s short-tailed bats (Carollia perspicillata) in the Brazilian Atlantic Rainforest3
The translational challenge in Chagas disease drug development3
Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report3
Microbiome and virome on indoor surfaces of an Antarctic research ship3
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts3
COVID-19 outbreaks among crew members in non-cruise vessels anchoring in Salvador, Brazil, 20213
Chagas disease treatment: a 120-year-old challenge to public health3
Critical analysis of Chagas disease treatment in different countries3
Cerebrospinal fluid: a target of some fungi and an overview3
Waiting for a success story in prevention, control and treatment of Chagas disease in non-endemic countries3
Population size regulation is density-dependent in Rhodnius prolixus (Hemiptera: Reduviidae) through an irritability mechanism3
Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis3
0.11421513557434